Correlation Between Rigel Pharmaceuticals and Gamida Cell
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Gamida Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Gamida Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Gamida Cell, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Gamida Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Gamida Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Gamida Cell.
Diversification Opportunities for Rigel Pharmaceuticals and Gamida Cell
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Rigel and Gamida is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Gamida Cell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gamida Cell and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Gamida Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gamida Cell has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Gamida Cell go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Gamida Cell
If you would invest 1,420 in Rigel Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 1,341 from holding Rigel Pharmaceuticals or generate 94.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Gamida Cell
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Gamida Cell |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Rigel Pharmaceuticals and Gamida Cell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Gamida Cell
The main advantage of trading using opposite Rigel Pharmaceuticals and Gamida Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Gamida Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gamida Cell will offset losses from the drop in Gamida Cell's long position.| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
| Gamida Cell vs. BioLineRx | Gamida Cell vs. Ardelyx | Gamida Cell vs. Lexicon Pharmaceuticals | Gamida Cell vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |